AlbionVC

AlbionVC is a London-based venture capital firm established in 1996, specializing in seed to series B investments. The firm focuses on a range of sectors, including healthcare, digital health, medtech, B2B software, SaaS, digital risk, fintech, artificial intelligence, deep tech, and life sciences. AlbionVC typically invests between £0.25 million and £10 million, supporting early-stage companies with long-term capital and expertise to help them scale. As a subsidiary of Albion Capital Group LLP, AlbionVC is authorized and regulated by the Financial Conduct Authority and is actively involved in over 50 companies within its investment portfolio.

Simon Goldman Ph.D

Partner

Tanel Ozdemir Ph.D

Investment Manager

Robert Whitby Smith

Partner

Pauline Stasiak Ph.D

Investment Manager

Past deals in United Kingdom

TransFICC

Series B in 2025
TransFICC Limited is an e-trading technology company based in London, United Kingdom, that specializes in providing application programming interfaces (APIs) for the fixed income and derivatives markets. Founded in 2016, the company addresses the issue of fragmentation within these markets by offering a unified API that simplifies connectivity for banks and asset managers. Clients connect once to TransFICC's platform, which then manages the connections to various electronic trading venues. The technology emphasizes low latency, scalability, and security, allowing clients to keep up with rapid price updates and compete effectively against high-frequency trading firms. Additionally, TransFICC provides microsecond timestamping of price and order messages, ensuring a comprehensive audit trail that supports Best Execution requirements. The company is dedicated solely to enhancing market access, facilitating easier upgrades when trading venues change their APIs compared to traditional enterprise systems.

Diffblue

Series A in 2024
Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Treefera

Series A in 2024
Treefera is an AI-enabled data management platform that focuses on enhancing transparency and accuracy in nature-based asset reporting. By integrating satellite, drone, and ground truth data with advanced AI algorithms, Treefera delivers essential data products and workflows for continuous monitoring, assurance, and risk evaluation. Its platform serves a diverse clientele, including project developers, biochar producers, registries, and financial services in the carbon credit market, along with bioenergy and supply chain companies. Covering numerous jurisdictions and over 500 registered forest projects and harvest sites, Treefera compiles an extensive array of environmental and forestry data. The platform also enables clients to integrate analytics through an API. Operating globally, Treefera has a presence in the US, UK, Europe, Latin America, and Asia, dedicated to making the potential of nature-based solutions visible to all.

Phasecraft

Series A in 2023
Phasecraft is a UK-based company founded in 2018 that develops quantum software aimed at enhancing the practical application of quantum computing. The firm focuses on creating algorithms for quantum information processors, including intermediate-scale devices and quantum computers. By leveraging its expertise in quantum science and engineering, Phasecraft addresses significant industrial challenges, such as optimizing key processes and exploring new materials. The company's software supports clients in investigating innovative quantum materials and developing advanced technologies, including batteries and efficient solar cells. Through its work, Phasecraft aims to facilitate breakthrough scientific discoveries and enable entrepreneurs to tackle pressing global issues more effectively.

Umedeor

Series A in 2023
Umedeor Ltd is a technology company that develops a platform designed to enhance data access for medical research and healthcare delivery. Incorporated in 2017 and based in London, with an additional office in New York, Umedeor's platform facilitates the management of research and clinical programs for healthcare providers, care agencies, charities, and research organizations. By automating the creation of prospective, protocolized patient registries, Umedeor enables healthcare sites to engage in multiple research programs simultaneously without increasing operational burdens. The platform also provides life science companies with access to high-quality regulatory data, allowing for compliant re-engagement with patients to further research and development initiatives.

Quantexa

Series E in 2023
Quantexa Limited is a global data and analytics software company based in London, United Kingdom, specializing in Contextual Decision Intelligence. Incorporated in 2016, Quantexa develops advanced entity resolution and network analytics technology that empowers organizations to improve their operational decisions by unifying siloed data and generating a comprehensive view of internal and external information. Its platform leverages artificial intelligence to uncover hidden risks and opportunities, providing critical insights into the relationships between individuals, organizations, and locations. Quantexa's solutions address challenges in areas such as fraud prevention, anti-money laundering, compliance, and customer insights, serving clients across financial services, corporate sectors, and public organizations worldwide. The company has established a strategic alliance with Accenture to enhance its offerings and expand its market reach.

Peppy

Series B in 2023
Peppy Health Ltd. operates an online marketplace in the United Kingdom that provides postnatal support for parents, along with other health services. Founded in 2018 and based in London, Peppy connects users with vetted professionals, including lactation consultants, sleep consultants, physiotherapists, and mental health practitioners. The platform also addresses broader health issues such as menopause, fertility, and men's and women's health, catering to underserved areas of healthcare. By partnering with employers, Peppy facilitates access to personalized support through its secure app, aiming to help employees manage their health effectively and enhance their overall well-being at work.

Diffblue

Series A in 2022
Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Runa

Series B in 2022
Runa is pioneering a first-of-its-kind payment rail capable of sending and accepting digital value at scale. With Runa, companies can pay the people they serve in any form of digital value, anywhere, instantly. The Runa Network provides a wide range of digital payout types including gift cards, prepaid cards, subscriptions, donations, cryptocurrencies and more. Legacy payment mechanisms struggle to adapt to low-volume, high-velocity transactions both locally and globally, such as sending payouts to gig workers, creators, or sending rewards to customers or employees wherever they are. Runa’s infrastructure and network facilitates payouts to these recipients, helping businesses expand their reach, retain their users while modernizing the way in which they manage and transfer money: instantly, internationally, and free of charge for the senders and the recipient. Runa was established as WeGift in October 2016 by Aron Alexander in London, England.

Healios

Series B in 2022
Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. It specializes in connecting mental health therapists with children and adults through an online platform that facilitates video calling. Healios provides a clinician-led online family intervention service, which includes interactive psychoeducation for family members and caregivers of individuals affected by mental illness. By integrating advanced technology with clinical expertise and a personal touch, Healios aims to empower patients and their families, helping them understand mental health challenges and adopt healthier habits. The company's mission is to enhance the delivery of care, enabling patients, families, and caregivers to achieve their goals and improve their quality of life.

OutThink

Seed Round in 2022
OutThink is a London-based cybersecurity start-up that specializes in a human risk management platform designed to enhance employee engagement and foster a risk-aware culture within organizations. Recognized for its innovative approach by industry leaders, the company offers a SaaS solution that identifies and mitigates risky behaviors among the workforce. By quantifying human risk, OutThink's platform enables organizations to tailor awareness training based on employee behaviors and attitudes, thereby improving cybersecurity engagement and productivity. This targeted approach not only reduces employee risk but also assists clients in complying with regulatory standards, addressing the increasing demand for a well-trained workforce in the face of rising cyber threats.

Toqio

Series A in 2022
Toqio is a company that provides a platform for organizations to develop their own fintech solutions, either as mobile applications or web-based services. Founded in 2019 by Eduardo Martinez and Michael Galvin, with offices in London, Madrid, and Nairobi, Toqio offers a configuration and customization platform supported by a marketplace of partners. The company specializes in software integration tools tailored for the financial industry, facilitating various services such as digital consumer and business banking, onboarding, transaction monitoring, and the distribution of financial products. By enabling companies to create data-driven financial propositions, Toqio helps them rapidly deploy solutions to meet the needs of their customers effectively.

Black Swan Data

Venture Round in 2022
Black Swan Data Limited, founded in 2011 and based in London, UK, develops a consumer intelligence platform that leverages artificial intelligence, deep learning, and natural language processing to provide predictive insights for businesses. The company's flagship product, Nest, specializes in data integration and classification, processing and enriching data for visualization. It combines clients' internal data with external factors affecting consumer demand, such as competitive activities and public events, to enhance marketing effectiveness and drive return on investment. By curating various conversations, Black Swan Data enables businesses to predict consumer behavior accurately, identify untapped opportunities, and make informed decisions to foster growth.

Speechmatics

Series B in 2022
Speechmatics Limited develops advanced speech recognition software that converts voice data into text for various applications, including analysis, discovery, and accessibility. Established in 2009 and headquartered in Cambridge, United Kingdom, the company provides its speech-to-text API for integration across diverse industries, allowing businesses to accurately transcribe human speech regardless of demographic factors such as age, gender, accent, or dialect. Its platform leverages machine learning technology to produce time-stamped documents in multiple languages, helping organizations generate valuable insights about customers and employees. This capability enhances operational efficiency and supports compliance, making Speechmatics a versatile solution for sectors like media broadcasting, contact centers, and transcription services.

TransFICC

Venture Round in 2022
TransFICC Limited is an e-trading technology company based in London, United Kingdom, that specializes in providing application programming interfaces (APIs) for the fixed income and derivatives markets. Founded in 2016, the company addresses the issue of fragmentation within these markets by offering a unified API that simplifies connectivity for banks and asset managers. Clients connect once to TransFICC's platform, which then manages the connections to various electronic trading venues. The technology emphasizes low latency, scalability, and security, allowing clients to keep up with rapid price updates and compete effectively against high-frequency trading firms. Additionally, TransFICC provides microsecond timestamping of price and order messages, ensuring a comprehensive audit trail that supports Best Execution requirements. The company is dedicated solely to enhancing market access, facilitating easier upgrades when trading venues change their APIs compared to traditional enterprise systems.

PerchPeek

Series A in 2022
PerchPeek Limited is an online platform based in London, United Kingdom, that facilitates property renting by connecting tenants with property providers. Founded in 2017, the company leverages artificial intelligence to serve as a home search assistant, streamlining the relocation process for individuals and groups. Its platform offers a range of services, including house-hunting, virtual tours of schools, and assistance with utility setups and shipping quotes. Additionally, PerchPeek provides customer support and a real-time dashboard for HR teams, helping to manage employee relocations and cost-of-living considerations. By guiding users through each stage of their move, PerchPeek enhances the overall experience of finding and settling into a new home.

Brytlyt

Series A in 2021
Brytlyt Limited, founded in 2013 and based in Maidstone, United Kingdom, specializes in developing a GPU-accelerated database and analytics platform. The company's flagship product, Brytlyt, is an all-in-one browser-led solution that integrates GPU in-database AI and deep learning capabilities, aiming to enhance data analytics at high speeds. Additionally, Brytlyt offers SpotLyt, which provides interactive analytics for row datasets. The platform features geospatial mapping, a SQL editor, and seamless integration with Jupyter Notebooks, allowing clients to manage data effectively and perform interactive drill-down analysis at individual data point levels. Brytlyt is focused on empowering data scientists and decision-makers with accessible tools for real-time analytics and visualization.

Elliptic

Series C in 2021
Elliptic Enterprises Limited operates a blockchain analytics and compliance platform focused on enhancing transparency and accountability in cryptocurrency transactions. Founded in 2013 and based in London, the company offers services such as Elliptic Vault for secure storage of digital currencies, alongside tools for identifying and managing financial crime risks associated with cryptocurrencies. Elliptic aims to combat illicit activities that jeopardize the integrity of the cryptocurrency ecosystem by providing actionable intelligence to cryptocurrency companies, financial institutions, and government agencies. Their efforts are geared towards strengthening anti-money laundering programs and ensuring compliance with regulatory requirements, thereby fostering a safer and more accountable environment for digital currencies.

Oviva

Series C in 2021
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.

Quantexa

Series D in 2021
Quantexa Limited is a global data and analytics software company based in London, United Kingdom, specializing in Contextual Decision Intelligence. Incorporated in 2016, Quantexa develops advanced entity resolution and network analytics technology that empowers organizations to improve their operational decisions by unifying siloed data and generating a comprehensive view of internal and external information. Its platform leverages artificial intelligence to uncover hidden risks and opportunities, providing critical insights into the relationships between individuals, organizations, and locations. Quantexa's solutions address challenges in areas such as fraud prevention, anti-money laundering, compliance, and customer insights, serving clients across financial services, corporate sectors, and public organizations worldwide. The company has established a strategic alliance with Accenture to enhance its offerings and expand its market reach.

Healios

Series A in 2021
Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. It specializes in connecting mental health therapists with children and adults through an online platform that facilitates video calling. Healios provides a clinician-led online family intervention service, which includes interactive psychoeducation for family members and caregivers of individuals affected by mental illness. By integrating advanced technology with clinical expertise and a personal touch, Healios aims to empower patients and their families, helping them understand mental health challenges and adopt healthier habits. The company's mission is to enhance the delivery of care, enabling patients, families, and caregivers to achieve their goals and improve their quality of life.

Panaseer

Series B in 2021
Panaseer Limited is a London-based company that specializes in cloud-based cybersecurity intelligence software designed for enterprise security. Founded in 2014, it offers a Continuous Controls Monitoring platform that provides real-time insights into every asset, application, user, and dataset within an organization. The platform enables security leaders to identify gaps in security controls, align with regulatory frameworks, and enhance decision-making across various organizational levels. By ingesting data from diverse sources, both in the cloud and on-premises, Panaseer helps organizations manage risk posture and improve cyber hygiene practices. Its automated reporting capabilities streamline the reporting process and tailor insights to stakeholders, facilitating risk prioritization based on business impact. The company also has an office in New York, enhancing its reach in the cybersecurity sector.

Solidatus

Series A in 2021
Solidatus is a leading provider of next-generation data lineage and conceptual modeling solutions that help organizations manage their metadata, data, and processes effectively. Recognized for its innovative approach, Solidatus enables large, data-rich organizations to enhance transparency, identify gaps, and streamline the implementation of changes. Its software not only demonstrates regulatory compliance and improves governance but also assists in transformational change and optimizes data landscapes by creating a connected digital map of an organization. This facilitates the management of data flows, supports cloud migration, and enables regulatory reporting, ultimately enhancing an organization's data economy. Solidatus has gained traction among top-tier firms in the financial, pharmaceutical, utility, and infrastructure sectors worldwide, and is expanding its presence in global markets, including plans for growth in the US, Europe, and the Middle East. The company is headquartered in London, with an office in Singapore.

Umedeor

Seed Round in 2020
Umedeor Ltd is a technology company that develops a platform designed to enhance data access for medical research and healthcare delivery. Incorporated in 2017 and based in London, with an additional office in New York, Umedeor's platform facilitates the management of research and clinical programs for healthcare providers, care agencies, charities, and research organizations. By automating the creation of prospective, protocolized patient registries, Umedeor enables healthcare sites to engage in multiple research programs simultaneously without increasing operational burdens. The platform also provides life science companies with access to high-quality regulatory data, allowing for compliant re-engagement with patients to further research and development initiatives.

Runa

Series A in 2020
Runa is pioneering a first-of-its-kind payment rail capable of sending and accepting digital value at scale. With Runa, companies can pay the people they serve in any form of digital value, anywhere, instantly. The Runa Network provides a wide range of digital payout types including gift cards, prepaid cards, subscriptions, donations, cryptocurrencies and more. Legacy payment mechanisms struggle to adapt to low-volume, high-velocity transactions both locally and globally, such as sending payouts to gig workers, creators, or sending rewards to customers or employees wherever they are. Runa’s infrastructure and network facilitates payouts to these recipients, helping businesses expand their reach, retain their users while modernizing the way in which they manage and transfer money: instantly, internationally, and free of charge for the senders and the recipient. Runa was established as WeGift in October 2016 by Aron Alexander in London, England.

Quantexa

Series C in 2020
Quantexa Limited is a global data and analytics software company based in London, United Kingdom, specializing in Contextual Decision Intelligence. Incorporated in 2016, Quantexa develops advanced entity resolution and network analytics technology that empowers organizations to improve their operational decisions by unifying siloed data and generating a comprehensive view of internal and external information. Its platform leverages artificial intelligence to uncover hidden risks and opportunities, providing critical insights into the relationships between individuals, organizations, and locations. Quantexa's solutions address challenges in areas such as fraud prevention, anti-money laundering, compliance, and customer insights, serving clients across financial services, corporate sectors, and public organizations worldwide. The company has established a strategic alliance with Accenture to enhance its offerings and expand its market reach.

TransFICC

Series A in 2020
TransFICC Limited is an e-trading technology company based in London, United Kingdom, that specializes in providing application programming interfaces (APIs) for the fixed income and derivatives markets. Founded in 2016, the company addresses the issue of fragmentation within these markets by offering a unified API that simplifies connectivity for banks and asset managers. Clients connect once to TransFICC's platform, which then manages the connections to various electronic trading venues. The technology emphasizes low latency, scalability, and security, allowing clients to keep up with rapid price updates and compete effectively against high-frequency trading firms. Additionally, TransFICC provides microsecond timestamping of price and order messages, ensuring a comprehensive audit trail that supports Best Execution requirements. The company is dedicated solely to enhancing market access, facilitating easier upgrades when trading venues change their APIs compared to traditional enterprise systems.

Concirrus

Series B in 2020
Concirrus Ltd., established in 2011 and headquartered in London, operates a cloud-based platform that connects diverse data sources and devices, enabling clients to extract and manage various data types. The company specializes in transforming businesses by leveraging its technology to collect, organize, and analyze information from connected products and machines. Concirrus offers custom solutions, including consultancy, implementation, and support services, as well as a portfolio of pre-built applications in areas such as asset security, fleet management, and smart energy. Its incident monitoring center responds to alarms for theft recovery and high-value asset security. Serving global clients in sectors like healthcare, security, mining, and insurance, Concirrus has a strategic partnership with PressurePro. Notably, the company's AI-driven marine insurance platform, Quest, empowers underwriting teams to make data-driven decisions, improving loss ratios and reducing operational expenses.

Hazy

Seed Round in 2020
Hazy Limited is a London-based company that specializes in data anonymization through artificial intelligence. Founded in 2017, Hazy develops a workflow tool that enables businesses to securely share and utilize data while complying with privacy regulations. The platform automatically anonymizes personal information, allowing organizations to handle evolving datasets without compromising sensitive data. By re-engineering enterprise data, Hazy empowers businesses to enhance decision-making, foster innovation, and create value, all while ensuring that data remains reliable, safe, and trusted. Hazy positions itself as a leader in the synthetic data space, addressing the growing demand for accessible and usable data in an increasingly regulated environment.

Oviva

Series B in 2020
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.

Speechmatics

Series A in 2019
Speechmatics Limited develops advanced speech recognition software that converts voice data into text for various applications, including analysis, discovery, and accessibility. Established in 2009 and headquartered in Cambridge, United Kingdom, the company provides its speech-to-text API for integration across diverse industries, allowing businesses to accurately transcribe human speech regardless of demographic factors such as age, gender, accent, or dialect. Its platform leverages machine learning technology to produce time-stamped documents in multiple languages, helping organizations generate valuable insights about customers and employees. This capability enhances operational efficiency and supports compliance, making Speechmatics a versatile solution for sectors like media broadcasting, contact centers, and transcription services.

Elliptic

Series B in 2019
Elliptic Enterprises Limited operates a blockchain analytics and compliance platform focused on enhancing transparency and accountability in cryptocurrency transactions. Founded in 2013 and based in London, the company offers services such as Elliptic Vault for secure storage of digital currencies, alongside tools for identifying and managing financial crime risks associated with cryptocurrencies. Elliptic aims to combat illicit activities that jeopardize the integrity of the cryptocurrency ecosystem by providing actionable intelligence to cryptocurrency companies, financial institutions, and government agencies. Their efforts are geared towards strengthening anti-money laundering programs and ensuring compliance with regulatory requirements, thereby fostering a safer and more accountable environment for digital currencies.

Koru Kids

Series A in 2019
Koru Kids Ltd. is a childcare service provider based in London, specializing in nanny shares that connect families with full-time nannies to those seeking part-time care. Established in 2016, the company aims to improve childcare options by creating a platform that facilitates the matching of families and nannies. Koru Kids focuses on ensuring high-quality and affordable childcare by streamlining the process of finding suitable after-school nannies. The team behind the company possesses experience in childcare, healthcare, and technology startups, reflecting their commitment to enhancing childcare services. Koru Kids is registered with the Information Commissioner's Office and is affiliated with the Financial Conduct Authority's Innovation Hub, indicating a strong regulatory compliance framework.

Clear Review

Series A in 2019
Clear Review Limited is a cloud-based performance management and engagement platform designed to facilitate ongoing employee feedback and continuous conversations between employees and managers. The platform includes features such as check-ins, real-time feedback, aligned SMART objectives, performance reviews, personal development plans, fast reporting, and video guidance. Clear Review serves a diverse range of sectors, including media, technology, financial services, healthcare, government, charities, education, publishing, aerospace, engineering, recruitment, professional services, film studios, and football clubs. Established in 2014 and based in London, the company was previously known as One Touch Apps Limited before rebranding in August 2019. Clear Review aims to empower human resources professionals and employees alike, fostering a culture of performance improvement through meaningful discussions and feedback.

Symetrica

Venture Round in 2019
Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.

Astroscreen

Seed Round in 2019
Astroscreen Ltd is a London-based company that specializes in developing a software as a service (SaaS) platform aimed at detecting astroturfing campaigns, which involve deceptive social media manipulation. Founded in 2018, the platform employs advanced machine learning techniques and human intelligence to identify fake accounts, botnets, and spam across social networks. By leveraging social media bot data, Astroscreen provides disinformation analysts with the tools needed to verify social media influence engagement and cleanse data streams. This enables organizations to combat marketing fraud, safeguard their brands, and obtain reliable insights into social media analytics.

Avora

Series A in 2019
Avora is a cloud-based business intelligence platform that leverages artificial intelligence and machine learning to enhance data analysis for organizations across various industries, including retail, financial services, and advertising. The platform simplifies the process of extracting valuable insights from data by allowing non-technical users to generate and share reports effortlessly, thus removing barriers to data accessibility. Avora's technology consolidates data from numerous sources and accelerates the time to insight, significantly reducing data preparation and discovery time by 50-80%. It also features automated anomaly detection, enabling businesses to respond proactively to potential issues. Headquartered in London, with additional offices in New York and Romania, Avora empowers companies to make informed decisions quickly, ultimately driving productivity and positive change.

Epsilogen

Series A in 2018
Epsilogen Ltd is an immuno-oncology company based in London, United Kingdom, founded in 2016. The company specializes in developing immunoglobulin E (IgE) antibodies aimed at treating cancer. Epsilogen offers a portfolio of IgE candidates that specifically target cancer antigens such as HER2, EGFR, and PD-L1. Its innovative IgE platform supports the development and validation of novel antibodies, allowing for enhanced potency, improved tumor access, and a prolonged presence in tissue. This focus on IgE-based therapies positions Epsilogen to provide effective treatment options for patients with solid tumors.

Arecor

Venture Round in 2018
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.

Phrasee

Series A in 2018
Phrasee Ltd. is a London-based company specializing in artificial intelligence-driven marketing language generation. Founded in 2015, Phrasee has developed advanced technology that predicts audience emotional responses and generates effective marketing copy. Its Natural Language Generation system can produce millions of human-like variations, optimizing subject lines for emails, body copy, trigger campaigns, and calls-to-action. By analyzing extensive language data, Phrasee's algorithms ensure that the generated content is tailored to specific brands, enhancing engagement and driving conversions. The company's innovative approach aims to revolutionize digital marketing by leveraging AI to create compelling language that outperforms traditional human-generated copy.

Quantexa

Series B in 2018
Quantexa Limited is a global data and analytics software company based in London, United Kingdom, specializing in Contextual Decision Intelligence. Incorporated in 2016, Quantexa develops advanced entity resolution and network analytics technology that empowers organizations to improve their operational decisions by unifying siloed data and generating a comprehensive view of internal and external information. Its platform leverages artificial intelligence to uncover hidden risks and opportunities, providing critical insights into the relationships between individuals, organizations, and locations. Quantexa's solutions address challenges in areas such as fraud prevention, anti-money laundering, compliance, and customer insights, serving clients across financial services, corporate sectors, and public organizations worldwide. The company has established a strategic alliance with Accenture to enhance its offerings and expand its market reach.

Hazy

Seed Round in 2018
Hazy Limited is a London-based company that specializes in data anonymization through artificial intelligence. Founded in 2017, Hazy develops a workflow tool that enables businesses to securely share and utilize data while complying with privacy regulations. The platform automatically anonymizes personal information, allowing organizations to handle evolving datasets without compromising sensitive data. By re-engineering enterprise data, Hazy empowers businesses to enhance decision-making, foster innovation, and create value, all while ensuring that data remains reliable, safe, and trusted. Hazy positions itself as a leader in the synthetic data space, addressing the growing demand for accessible and usable data in an increasingly regulated environment.

Panaseer

Series A in 2018
Panaseer Limited is a London-based company that specializes in cloud-based cybersecurity intelligence software designed for enterprise security. Founded in 2014, it offers a Continuous Controls Monitoring platform that provides real-time insights into every asset, application, user, and dataset within an organization. The platform enables security leaders to identify gaps in security controls, align with regulatory frameworks, and enhance decision-making across various organizational levels. By ingesting data from diverse sources, both in the cloud and on-premises, Panaseer helps organizations manage risk posture and improve cyber hygiene practices. Its automated reporting capabilities streamline the reporting process and tailor insights to stakeholders, facilitating risk prioritization based on business impact. The company also has an office in New York, enhancing its reach in the cybersecurity sector.

Healios

Venture Round in 2018
Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. It specializes in connecting mental health therapists with children and adults through an online platform that facilitates video calling. Healios provides a clinician-led online family intervention service, which includes interactive psychoeducation for family members and caregivers of individuals affected by mental illness. By integrating advanced technology with clinical expertise and a personal touch, Healios aims to empower patients and their families, helping them understand mental health challenges and adopt healthier habits. The company's mission is to enhance the delivery of care, enabling patients, families, and caregivers to achieve their goals and improve their quality of life.

Koru Kids

Seed Round in 2018
Koru Kids Ltd. is a childcare service provider based in London, specializing in nanny shares that connect families with full-time nannies to those seeking part-time care. Established in 2016, the company aims to improve childcare options by creating a platform that facilitates the matching of families and nannies. Koru Kids focuses on ensuring high-quality and affordable childcare by streamlining the process of finding suitable after-school nannies. The team behind the company possesses experience in childcare, healthcare, and technology startups, reflecting their commitment to enhancing childcare services. Koru Kids is registered with the Information Commissioner's Office and is affiliated with the Financial Conduct Authority's Innovation Hub, indicating a strong regulatory compliance framework.

MeiraGTx Holdings

Venture Round in 2017
MeiraGTx Holdings is a clinical-stage gene therapy company dedicated to developing and commercializing innovative gene therapy products aimed at transforming the lives of patients with acquired and inherited disorders. The company focuses on addressing serious medical conditions, primarily targeting disorders related to the eye, salivary gland, and central nervous system. Its research and development efforts leverage a portfolio approach, which includes licensing, acquiring, and developing advanced technologies to support a diverse range of product candidates. Key pipeline products include AAV-CNGB3, AAV-CNGA3, and AAV-RPGR, among others. MeiraGTx operates in the United States, the United Kingdom, and the European Union, with plans to expand its focus to develop additional gene therapy treatments for various serious diseases in the future.

Oviva

Series A in 2017
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.

Panaseer

Seed Round in 2017
Panaseer Limited is a London-based company that specializes in cloud-based cybersecurity intelligence software designed for enterprise security. Founded in 2014, it offers a Continuous Controls Monitoring platform that provides real-time insights into every asset, application, user, and dataset within an organization. The platform enables security leaders to identify gaps in security controls, align with regulatory frameworks, and enhance decision-making across various organizational levels. By ingesting data from diverse sources, both in the cloud and on-premises, Panaseer helps organizations manage risk posture and improve cyber hygiene practices. Its automated reporting capabilities streamline the reporting process and tailor insights to stakeholders, facilitating risk prioritization based on business impact. The company also has an office in New York, enhancing its reach in the cybersecurity sector.

Quantexa

Series A in 2017
Quantexa Limited is a global data and analytics software company based in London, United Kingdom, specializing in Contextual Decision Intelligence. Incorporated in 2016, Quantexa develops advanced entity resolution and network analytics technology that empowers organizations to improve their operational decisions by unifying siloed data and generating a comprehensive view of internal and external information. Its platform leverages artificial intelligence to uncover hidden risks and opportunities, providing critical insights into the relationships between individuals, organizations, and locations. Quantexa's solutions address challenges in areas such as fraud prevention, anti-money laundering, compliance, and customer insights, serving clients across financial services, corporate sectors, and public organizations worldwide. The company has established a strategic alliance with Accenture to enhance its offerings and expand its market reach.

Convertr

Series A in 2016
Convertr Media Limited operates a cloud-based customer acquisition platform designed for brands, publishers, and agencies across consumer and B2B markets. Founded in 2011 and headquartered in London, the platform facilitates multi-channel acquisition campaigns by utilizing customer data to enhance sales and demonstrate real-time return on investment. It aids publishers in improving audience profiles and increasing revenue from campaigns while allowing agencies to automate client acquisition efforts, thereby reducing workloads and enhancing client ROI. Convertr's API-first architecture serves as a data optimization tool, filtering and normalizing data to ensure accuracy and compliance before routing it to various endpoints. The platform is not a lead or data provider but rather a comprehensive solution for customer acquisition management and automated lead management, helping organizations become more scalable and data-driven.

Black Swan Data

Series B in 2016
Black Swan Data Limited, founded in 2011 and based in London, UK, develops a consumer intelligence platform that leverages artificial intelligence, deep learning, and natural language processing to provide predictive insights for businesses. The company's flagship product, Nest, specializes in data integration and classification, processing and enriching data for visualization. It combines clients' internal data with external factors affecting consumer demand, such as competitive activities and public events, to enhance marketing effectiveness and drive return on investment. By curating various conversations, Black Swan Data enables businesses to predict consumer behavior accurately, identify untapped opportunities, and make informed decisions to foster growth.

Orchard Therapeutics

Series A in 2016
Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. The company employs an autologous ex vivo gene therapy approach, which aims to modify a patient's hematopoietic stem cells to create a personalized treatment through a single administration. Orchard's product portfolio includes Strimvelis, the first gene therapy approved by the European Medicines Agency for adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company is advancing several clinical programs, including OTL-101 for ADA-SCID, OTL-200 for metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Additionally, Orchard has a robust preclinical pipeline targeting various mucopolysaccharidosis types. Founded in 2015, Orchard Therapeutics collaborates with leading institutions in the field to enhance its research and development efforts.

InCrowd Sports

Seed Round in 2016
InCrowd Sports Limited is a mobile fan engagement and sports marketing company based in London, United Kingdom, established in 2014. The company develops club mobile applications that provide real-time content, match analysis, and gamification tools designed to enhance the experience for fans, clubs, and sponsors. InCrowd Sports leverages cutting-edge technology to improve mobile connectivity within stadiums, enabling fans to share information seamlessly. Additionally, the company offers tools for creating mobile sponsorship inventory, allowing brands to interact with fans through engaging features such as predictors, quizzes, and games. By combining expertise from various sectors within sports, InCrowd Sports aims to significantly elevate the in-stadia experience.

Grapeshot

Series C in 2016
Grapeshot, established in 2002, is a software company specializing in contextual intelligence solutions for marketers and advertising agencies. Headquartered in Cambridge, UK, with global offices, it offers a platform that enables real-time targeting, data enrichment, and audience discovery. Grapeshot's key solutions include custom and predictive targeting, brand safety, GDPR compliance, campaign analytics, and audience segmentation. Serving brands, DSPs, media agencies, platforms, publishers, and trading desks, it empowers businesses to improve media efficiency, customer engagement, and brand perception. Post-acquisition by Oracle in 2018, Grapeshot continues to be recognized for its innovative tools, winning awards such as "Digiday's Best Publisher Tool" and "British Media Awards' Ad Provider of the Year."

Panaseer

Seed Round in 2015
Panaseer Limited is a London-based company that specializes in cloud-based cybersecurity intelligence software designed for enterprise security. Founded in 2014, it offers a Continuous Controls Monitoring platform that provides real-time insights into every asset, application, user, and dataset within an organization. The platform enables security leaders to identify gaps in security controls, align with regulatory frameworks, and enhance decision-making across various organizational levels. By ingesting data from diverse sources, both in the cloud and on-premises, Panaseer helps organizations manage risk posture and improve cyber hygiene practices. Its automated reporting capabilities streamline the reporting process and tailor insights to stakeholders, facilitating risk prioritization based on business impact. The company also has an office in New York, enhancing its reach in the cybersecurity sector.

Abcodia

Series B in 2015
Abcodia Ltd. is a biotechnology company that specializes in the discovery and validation of molecular biomarkers to enhance disease diagnosis and screening, particularly for cancer. The company offers the Roca Test, which is designed for early detection of ovarian cancer, serving clients across various states in the United States as well as in the United Kingdom. Abcodia leverages a unique longitudinal serum biobank and collaborates with institutions like University College London and major diagnostic firms to facilitate comprehensive diagnostic development. Founded in 2010, Abcodia is headquartered in London, United Kingdom.

Aridhia Informatics

Venture Round in 2014
Aridhia Informatics Ltd. specializes in biomedical informatics and analytics, offering solutions that support stratified medicine and translational research. Founded in 2007 and headquartered in Glasgow, United Kingdom, the company provides tools for patient tracking, infection control, and long-term condition management. Its services include clinical dashboards and research support for healthcare professionals, patients, and policymakers, primarily in the UK. Aridhia emphasizes the integration of patient, clinical, and genomic data to enhance understanding, diagnosis, prevention, and treatment of chronic diseases. By collaborating with clinical experts, Aridhia aims to empower patients in their healthcare journey and deliver insights into disease trends and public health initiatives. The company has established strategic partnerships with GoPivotal, Inc. and Glencoe Software, Inc. to further its mission in the healthcare sector.

Exco inTouch

Venture Round in 2014
Exco inTouch Ltd is a provider of patient engagement and data capture solutions for clinical trials and healthcare programs, operating in the United Kingdom and internationally. Founded in 2004 and headquartered in Nottingham, the company offers a comprehensive application system called Gather, which facilitates two-way communication between patients, site managers, and study teams while ensuring compliance with study protocols. In addition to clinical trial support, Exco inTouch develops disease management programs that create condition-specific care plans, helping patients understand their conditions, adhere to treatment regimens, and effectively manage their health. The company's digital health platform has been applied across various therapeutic areas, including diabetes, dermatology, respiratory diseases, and haemophilia. As of December 2016, Exco inTouch operates as a subsidiary of eResearchTechnology, Inc.

Mirada Medical

Venture Round in 2014
Mirada Medical Limited is a developer of medical imaging software applications, enhancing patient outcomes in radiology, molecular imaging, radiation oncology, and multidisciplinary meetings across hospitals, imaging centers, and cancer centers. The company offers several key products, including Mirada XD, an enterprise software for nuclear medicine and image fusion; DLCExpert, which provides automated organ-at-risk contouring services; and Mirada IM, supporting interventional medicine, particularly in optimizing radioembolization therapy. Established in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, Mirada Medical sells its solutions through direct sales and distribution channels, focusing on integrating advanced technology with practical applications for the diagnosis and treatment of cancer and other diseases.

Abcodia

Venture Round in 2014
Abcodia Ltd. is a biotechnology company that specializes in the discovery and validation of molecular biomarkers to enhance disease diagnosis and screening, particularly for cancer. The company offers the Roca Test, which is designed for early detection of ovarian cancer, serving clients across various states in the United States as well as in the United Kingdom. Abcodia leverages a unique longitudinal serum biobank and collaborates with institutions like University College London and major diagnostic firms to facilitate comprehensive diagnostic development. Founded in 2010, Abcodia is headquartered in London, United Kingdom.

Perpetuum

Series C in 2014
Perpetuum Ltd. specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 and based in Southampton, United Kingdom, the company focuses on creating battery-free vibration energy harvesters and wireless sensor nodes for various applications, including rail, oil and gas, chemicals, power generation, and water treatment. Perpetuum's technology converts mechanical vibrations into electrical energy, enabling autonomous, maintenance-free wireless sensors that monitor equipment conditions and processes. This innovative approach enhances efficiency and safety in fleet management and services, particularly within the rail industry. As a technology spin-off from the University of Southampton, Perpetuum has established itself as a leader in vibration energy harvesting, providing practical solutions for wireless automation.

Proveca

Venture Round in 2014
Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, that specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet healthcare needs in the pediatric market. Founded in 2010, Proveca focuses on developing formulations and clinical data necessary to obtain Pediatric Use Marketing Authorisation (PUMA) for its products, which include treatments for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain. The company seeks to secure market protection and exclusivity for its medicines by pursuing PUMA and, where applicable, Orphan Drug status. By doing so, Proveca aims to ensure that its licensed medicines are commercially viable and beneficial for children, either through direct commercialization or by selling the licenses to larger pharmaceutical firms.

Cisiv

Venture Round in 2014
Cisiv Ltd specializes in developing innovative technology solutions for the pharmaceutical and biotech industries, as well as research organizations and academic institutions. The company offers Baseline Plus, a data capture platform tailored for non-interventional studies, which facilitates the execution of complex, large-scale multinational research in a streamlined and cost-effective manner. This platform enhances communication among study groups, supports data entry, improves data quality and workflow, and incorporates features like online community engagement and translation capabilities. Through its web-based tools, Cisiv enables efficient data collection and management, allowing clients to gain valuable insights into the real-world application of their products and treatments. Established in 1995, Cisiv is headquartered in Kingston upon Thames, United Kingdom.

Blackbay

Venture Round in 2014
Blackbay Ltd, established in 2004 and headquartered in Derby, UK, specializes in designing and developing mobility-enabled solutions for the transport and logistics industry. The company offers cloud-based platforms such as Delivery Connect for real-time freight tracking, No Trucking Worries for driver and dispatcher management, and Expect for consumer communication during delivery and collection. Blackbay's solutions are used by over 55,000 mobile workers worldwide, serving prominent clients like Royal Mail, DHL, and Dyson. The company partners with industry leaders like ALK Technologies and Accenture, and as of 2017, operates as a subsidiary of BluJay Solutions Ltd.

Mirada Medical

Venture Round in 2014
Mirada Medical Limited is a developer of medical imaging software applications, enhancing patient outcomes in radiology, molecular imaging, radiation oncology, and multidisciplinary meetings across hospitals, imaging centers, and cancer centers. The company offers several key products, including Mirada XD, an enterprise software for nuclear medicine and image fusion; DLCExpert, which provides automated organ-at-risk contouring services; and Mirada IM, supporting interventional medicine, particularly in optimizing radioembolization therapy. Established in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, Mirada Medical sells its solutions through direct sales and distribution channels, focusing on integrating advanced technology with practical applications for the diagnosis and treatment of cancer and other diseases.

Grapeshot

Venture Round in 2014
Grapeshot, established in 2002, is a software company specializing in contextual intelligence solutions for marketers and advertising agencies. Headquartered in Cambridge, UK, with global offices, it offers a platform that enables real-time targeting, data enrichment, and audience discovery. Grapeshot's key solutions include custom and predictive targeting, brand safety, GDPR compliance, campaign analytics, and audience segmentation. Serving brands, DSPs, media agencies, platforms, publishers, and trading desks, it empowers businesses to improve media efficiency, customer engagement, and brand perception. Post-acquisition by Oracle in 2018, Grapeshot continues to be recognized for its innovative tools, winning awards such as "Digiday's Best Publisher Tool" and "British Media Awards' Ad Provider of the Year."

Abcodia

Venture Round in 2014
Abcodia Ltd. is a biotechnology company that specializes in the discovery and validation of molecular biomarkers to enhance disease diagnosis and screening, particularly for cancer. The company offers the Roca Test, which is designed for early detection of ovarian cancer, serving clients across various states in the United States as well as in the United Kingdom. Abcodia leverages a unique longitudinal serum biobank and collaborates with institutions like University College London and major diagnostic firms to facilitate comprehensive diagnostic development. Founded in 2010, Abcodia is headquartered in London, United Kingdom.

Cisiv

Venture Round in 2013
Cisiv Ltd specializes in developing innovative technology solutions for the pharmaceutical and biotech industries, as well as research organizations and academic institutions. The company offers Baseline Plus, a data capture platform tailored for non-interventional studies, which facilitates the execution of complex, large-scale multinational research in a streamlined and cost-effective manner. This platform enhances communication among study groups, supports data entry, improves data quality and workflow, and incorporates features like online community engagement and translation capabilities. Through its web-based tools, Cisiv enables efficient data collection and management, allowing clients to gain valuable insights into the real-world application of their products and treatments. Established in 1995, Cisiv is headquartered in Kingston upon Thames, United Kingdom.

Proveca

Venture Round in 2013
Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, that specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet healthcare needs in the pediatric market. Founded in 2010, Proveca focuses on developing formulations and clinical data necessary to obtain Pediatric Use Marketing Authorisation (PUMA) for its products, which include treatments for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain. The company seeks to secure market protection and exclusivity for its medicines by pursuing PUMA and, where applicable, Orphan Drug status. By doing so, Proveca aims to ensure that its licensed medicines are commercially viable and beneficial for children, either through direct commercialization or by selling the licenses to larger pharmaceutical firms.

Workshare

Debt Financing in 2012
Workshare is a company that provides a cloud-enabled platform designed to facilitate the comparison, protection, and sharing of high-stakes documents across various devices. Its innovative solutions allow content owners to track and compare amendments made by multiple contributors, ensuring secure and collaborative workflows. The company's offerings include tools for viewing, commenting, searching, storing, and managing files, catering to the needs of professionals in dynamic work environments. Headquartered in London, Workshare also has offices in the United States and Australia, serving over two million users in 70 countries. The platform is accessible on desktop, mobile, and tablet devices, enabling effective collaboration and control over document changes.

Abcodia

Venture Round in 2011
Abcodia Ltd. is a biotechnology company that specializes in the discovery and validation of molecular biomarkers to enhance disease diagnosis and screening, particularly for cancer. The company offers the Roca Test, which is designed for early detection of ovarian cancer, serving clients across various states in the United States as well as in the United Kingdom. Abcodia leverages a unique longitudinal serum biobank and collaborates with institutions like University College London and major diagnostic firms to facilitate comprehensive diagnostic development. Founded in 2010, Abcodia is headquartered in London, United Kingdom.

Celoxica

Venture Round in 2011
Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Oxsensis

Series C in 2010
Oxsensis Ltd. is a manufacturer of non-electrical optical sensors designed for extreme environments, focusing on applications in aerospace, power generation, oil and gas, and nuclear industries. Founded in 2003 and headquartered in Didcot, United Kingdom, the company specializes in optical pressure sensor systems, temperature transducers, and optical accelerometers. Its product lineup includes the Wave-Phire Dynamic Pressure Transducer for harsh atmospheres, the i-Phire 4 Channel Optical Interrogator Unit for converting optical signals into voltage signals, and S-Phire software for combustion monitoring. These sensors provide high sensitivity and immunity to electromagnetic interference, optimizing performance in demanding conditions. Oxsensis also supports various markets, including energy production, emissions monitoring, and high-temperature equipment health monitoring, with additional offices in the United States, Russia, China, and Japan.

Oxsensis

Venture Round in 2007
Oxsensis Ltd. is a manufacturer of non-electrical optical sensors designed for extreme environments, focusing on applications in aerospace, power generation, oil and gas, and nuclear industries. Founded in 2003 and headquartered in Didcot, United Kingdom, the company specializes in optical pressure sensor systems, temperature transducers, and optical accelerometers. Its product lineup includes the Wave-Phire Dynamic Pressure Transducer for harsh atmospheres, the i-Phire 4 Channel Optical Interrogator Unit for converting optical signals into voltage signals, and S-Phire software for combustion monitoring. These sensors provide high sensitivity and immunity to electromagnetic interference, optimizing performance in demanding conditions. Oxsensis also supports various markets, including energy production, emissions monitoring, and high-temperature equipment health monitoring, with additional offices in the United States, Russia, China, and Japan.

Dexela

Venture Round in 2006
Dexela develops advanced 3-D breast imaging technology aimed at the early detection of breast cancer. The company offers a range of products, including the DexTop Digital Mammography Workstation, which streamlines screening workflow and performance, and a 3D reconstruction engine available to OEM partners as a software module. Dexela's flat panel CMOS X-ray detectors serve various medical applications, such as mammography, breast CT, dental imaging, and fluoroscopy. Additionally, the company provides consulting services in digital tomosynthesis, mammography acquisition geometry, and the optimal reconstruction of 3D data. Founded in 2003 and headquartered in London, Dexela also operates an X-ray research and development facility in Sudbury, Massachusetts.

Blackbay

Venture Round in 2006
Blackbay Ltd, established in 2004 and headquartered in Derby, UK, specializes in designing and developing mobility-enabled solutions for the transport and logistics industry. The company offers cloud-based platforms such as Delivery Connect for real-time freight tracking, No Trucking Worries for driver and dispatcher management, and Expect for consumer communication during delivery and collection. Blackbay's solutions are used by over 55,000 mobile workers worldwide, serving prominent clients like Royal Mail, DHL, and Dyson. The company partners with industry leaders like ALK Technologies and Accenture, and as of 2017, operates as a subsidiary of BluJay Solutions Ltd.

ClusterSeven

Series A in 2006
ClusterSeven Ltd. is a company specializing in enterprise-wide spreadsheet and data management software, primarily serving financial institutions and reporting divisions. Founded in 2003 and headquartered in London, with an additional office in New York, ClusterSeven offers tools such as the Enterprise Spreadsheet Manager and Access Database Manager. These products monitor and track critical spreadsheets and Microsoft Access databases, allowing organizations to manage governance, risk, and regulatory compliance effectively. By identifying and classifying potential risks associated with individual spreadsheets, ClusterSeven enhances oversight and transparency, making its solutions valuable to clients across various sectors, including capital markets, retail banking, asset management, hedge funds, insurance, energy, pharmaceuticals, and audit firms.

Bango

Venture Round in 2004
Bango plc is a technology company based in Cambridge, United Kingdom, specializing in mobile payment solutions for content and services. Founded in 1999, Bango develops, markets, and sells technology that facilitates the marketing and sale of products directly to mobile phone users. The company operates through two segments: End User Activity and Data Activity. Its key offering, the Bango Payment Platform, enables app stores and content providers to establish billing connections with mobile operators globally, thereby streamlining the payment process for users. In addition to this platform, Bango offers products such as Bango Marketplace, which aids developers in targeting specific customer audiences, and Bango Resale, which helps merchants acquire and retain customers through global partnerships. The company also features Audiens, a mobile data exchange platform, and partners with leading global stores and payment providers to enhance user engagement and revenue generation. Bango's operations extend across the United Kingdom, European Union, the United States, Canada, and internationally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.